web analytics
21.1 C
Munich
Sunday, July 3, 2022
type here...

CATEGORY

BioPharma

BioPharma

Gold Entertainment Group (OTCMKTS: GEGP) Breaking Out Northbound as New Management Looks to go Pink Current & Affect Reverse Merger

Boe Rimes -
Gold Entertainment Group (OTCMKTS: GEGP) has awaking from the long downward drift following the last promotion on GEGP in October 2021 when the stock...
BioPharma

Southern Home Medical (OTCMKTS: SHOM) Low Float Sub Penny Comes Back to Life as Co goes “Pink Current” & Management Gets Busy on Twitter

Boe Rimes -
Southern Home Medical (OTCMKTS: SHOM) has been rising steadily up the charts in recent days ever since the Company got their filings up to...
BioPharma

Navigating through the Galectin Therapeutics (NASDAQ: GALT) Triangle In Search of Therapies

Boe Rimes -
Galectin Therapeutics (NASDAQ: GALT), Galecto Biotech (NASDAQ: GLTO), and BioXyTran Inc. (OTCMKTS: BIXT)—these three companies all currently have market capitalizations under $100 million in...
BioPharma

Genocea Biosciences Inc (OTCMKTS: GNCA) Ex NASDAQ Biotech Heating up and Making Moves on the OTC As Co Winds Down Operations

Boe Rimes -
Genocea Biosciences Inc (OTCMKTS: GNCA) is coming up off $0.012 lows reached shortly after GNCA began trading on the OTC pink sheets. The stock...
BioPharma

Plandai Biotechnology Inc (OTCMKTS: PLPL) Biotech Reverse Merger & FDA Approved Puriblood Leukocyte Reduction Blood Filtration System Looks to Go Public via Plandai

Boe Rimes -
Plandai Biotechnology Inc (OTCMKTS: PLPL) has been moving northbound trading over $280,000 in dollar volume and moving up 40% on Tuesday. The stock was...
BioPharma

Solar Integrated Roofing Corp. (OTC:SIRC) Heats Up as the Company Cancels 45 Million Shares (Record Revenues and Up Listing to National Exchange)

Boe Rimes -
Solar Integrated Roofing Corp. (OTC:SIRC) made a powerful reversal northbound on Tuesday after the Company announced the amicable settlement of the pending legal action...
1234...31Page 3 of 31

Latest news

© All rights reserved.

About Us

Popular Category

Editor Picks